Annual Net Income
-$135.35 M
-$26.85 M-24.75%
31 December 2023
Summary:
Monte Rosa Therapeutics annual net profit is currently -$135.35 million, with the most recent change of -$26.85 million (-24.75%) on 31 December 2023. During the last 3 years, it has fallen by -$99.47 million (-277.25%). GLUE annual net income is now -1648.73% below its all-time high of -$7.74 million, reached on 31 December 2019.GLUE Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$23.86 M
+$6.45 M+21.28%
30 September 2024
Summary:
Monte Rosa Therapeutics quarterly net profit is currently -$23.86 million, with the most recent change of +$6.45 million (+21.28%) on 30 September 2024. Over the past year, it has increased by +$11.03 million (+31.60%). GLUE quarterly net income is now -454.60% below its all-time high of -$4.30 million, reached on 31 March 2020.GLUE Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$119.39 M
+$11.03 M+8.45%
30 September 2024
Summary:
Monte Rosa Therapeutics TTM net profit is currently -$119.39 million, with the most recent change of +$11.03 million (+8.45%) on 30 September 2024. Over the past year, it has increased by +$13.49 million (+10.15%). GLUE TTM net income is now -2675.20% below its all-time high of -$4.30 million, reached on 31 March 2020.GLUE TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GLUE Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -24.8% | +31.6% | +10.2% |
| 3 y3 years | -277.3% | -20.3% | -70.1% |
| 5 y5 years | - | - | - |
GLUE Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -277.3% | at low | -20.3% | +32.2% | -70.1% | +11.8% |
| 5 y | 5 years | -1648.7% | at low | -454.6% | +32.2% | -2675.2% | +11.8% |
| alltime | all time | -1648.7% | at low | -454.6% | +32.2% | -2675.2% | +11.8% |
Monte Rosa Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$23.86 M(-21.3%) | -$119.39 M(-8.5%) |
| June 2024 | - | -$30.31 M(-5.2%) | -$130.41 M(-3.6%) |
| Mar 2024 | - | -$31.97 M(-3.9%) | -$135.28 M(-0.1%) |
| Dec 2023 | -$135.35 M(+24.7%) | -$33.25 M(-4.7%) | -$135.35 M(+1.9%) |
| Sept 2023 | - | -$34.88 M(-0.8%) | -$132.88 M(+6.0%) |
| June 2023 | - | -$35.18 M(+9.8%) | -$125.32 M(+7.5%) |
| Mar 2023 | - | -$32.04 M(+4.1%) | -$116.61 M(+7.5%) |
| Dec 2022 | -$108.50 M | -$30.78 M(+12.7%) | -$108.50 M(+7.3%) |
| Sept 2022 | - | -$27.32 M(+3.2%) | -$101.16 M(+8.0%) |
| June 2022 | - | -$26.47 M(+10.6%) | -$93.68 M(+9.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$23.93 M(+2.1%) | -$85.61 M(+15.8%) |
| Dec 2021 | -$73.96 M(+106.1%) | -$23.44 M(+18.2%) | -$73.96 M(+5.4%) |
| Sept 2021 | - | -$19.84 M(+7.8%) | -$70.17 M(+23.3%) |
| June 2021 | - | -$18.41 M(+49.9%) | -$56.90 M(+29.7%) |
| Mar 2021 | - | -$12.28 M(-37.5%) | -$43.85 M(+22.2%) |
| Dec 2020 | -$35.88 M(+363.6%) | -$19.66 M(+199.7%) | -$35.88 M(+121.2%) |
| Sept 2020 | - | -$6.56 M(+22.3%) | -$16.22 M(+67.8%) |
| June 2020 | - | -$5.36 M(+24.7%) | -$9.67 M(+124.7%) |
| Mar 2020 | - | -$4.30 M | -$4.30 M |
| Dec 2019 | -$7.74 M | - | - |
FAQ
- What is Monte Rosa Therapeutics annual net profit?
- What is the all time high annual net income for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics annual net income year-on-year change?
- What is Monte Rosa Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics quarterly net income year-on-year change?
- What is Monte Rosa Therapeutics TTM net profit?
- What is the all time high TTM net income for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics TTM net income year-on-year change?
What is Monte Rosa Therapeutics annual net profit?
The current annual net income of GLUE is -$135.35 M
What is the all time high annual net income for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high annual net profit is -$7.74 M
What is Monte Rosa Therapeutics annual net income year-on-year change?
Over the past year, GLUE annual net profit has changed by -$26.85 M (-24.75%)
What is Monte Rosa Therapeutics quarterly net profit?
The current quarterly net income of GLUE is -$23.86 M
What is the all time high quarterly net income for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high quarterly net profit is -$4.30 M
What is Monte Rosa Therapeutics quarterly net income year-on-year change?
Over the past year, GLUE quarterly net profit has changed by +$11.03 M (+31.60%)
What is Monte Rosa Therapeutics TTM net profit?
The current TTM net income of GLUE is -$119.39 M
What is the all time high TTM net income for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high TTM net profit is -$4.30 M
What is Monte Rosa Therapeutics TTM net income year-on-year change?
Over the past year, GLUE TTM net profit has changed by +$13.49 M (+10.15%)